Literature DB >> 19483767

Oncolytic viruses: time to compare, contrast, and combine? 5th international meeting on replicating oncolytic virus therapeutics. Banff, Alberta, Canada, 18-22 March 2009.

Hardev Pandha1, Alan Melcher, Kevin Harrington, Richard Vile.   

Abstract

Mesh：

Year:  2009        PMID： 19483767      PMCID： PMC2835190          DOI： 10.1038/mt.2009.86

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  Oncolytic viruses: now interviewing for the all-star game.

Authors:  Richard Vile
Journal:  Mol Ther       Date:  2010-05       Impact factor: 11.454

Review 2.  Current issues and future directions of oncolytic adenoviruses.

Authors:  Masato Yamamoto; David T Curiel
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

Review 3.  The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.

Authors:  Robin J Prestwich; Fiona Errington; Rosa M Diaz; Hardev S Pandha; Kevin J Harrington; Alan A Melcher; Richard G Vile
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

4.  Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.

Authors:  Samuel T Workenhe; Graydon Simmons; Jonathan G Pol; Brian D Lichty; William P Halford; Karen L Mossman
Journal:  Mol Ther       Date:  2013-10-09       Impact factor: 11.454

Review 5.  Virotherapy in cancer.

Authors:  Gholamreza Motalleb
Journal:  Iran J Cancer Prev       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.